Pfizer (PFE)

Pfizer Stock Analysis & Ratings


PFE Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$39.64 - $60.28
Previous Close$49.86
Average Volume (3M)20.65M
Market CapN/A
Enterprise ValueN/A
P/E Ratio9.8
Next EarningsNov 01, 2022
Dividend Yield1.59 (3.19%)
Smart Score5
EPS (TTM)5.11
Shares Outstanding5,610,895,801
Standard Deviation0.07
10 Day Avg. Volume15,061,803
30 Day Avg. Volume20,647,030
P/B Ratio122.42
P/S Ratio3.97
P/CF Ratio8.70
P/FCF Ratio35.90
Total Debt$34.93B
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside25.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Pfizer’s price range in the past 12 months?
Pfizer lowest stock price was $39.64 and its highest was $60.28 in the past 12 months.
    What is Pfizer’s market cap?
    Currently, no data Available
    What is Pfizer’s price target?
    The average price target for Pfizer is $61.75. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $105.00 ,the lowest forecast is $49.00. The average price target represents 25.33% Increase from the current price of $49.27.
      What do analysts say about Pfizer?
      Pfizer’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
        When is Pfizer’s upcoming earnings report date?
        Pfizer’s upcoming earnings report date is Nov 01, 2022 which is in 74 days.
          How were Pfizer’s earnings last quarter?
          Pfizer released its earnings results on Jul 28, 2022. The company reported $2.04 earnings per share for the quarter, beating the consensus estimate of $1.724 by $0.316.
            Is Pfizer overvalued?
            According to Wall Street analysts Pfizer’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does Pfizer pay dividends?
              Pfizer pays a Quarterly dividend of $0.4 which represents an annual dividend yield of 3.19%. Pfizer’s last Quarterly dividend payment was on Sep 06, 2022. Pfizer’s upcoming ex-dividend date is Jul 28, 2022
                What is Pfizer’s EPS estimate?
                Pfizer’s EPS estimate is $1.5.
                  How many shares outstanding does Pfizer have?
                  Pfizer has 5,610,896,000 shares outstanding.
                    What happened to Pfizer’s price movement after its last earnings report?
                    Pfizer reported an EPS of $2.04 in its last earnings report, beating expectations of $1.724. Following the earnings report the stock price went down -1.61%.
                      Which hedge fund is a major shareholder of Pfizer?
                      Among the largest hedge funds holding Pfizer’s share is Diamond Hill Capital Management Inc. It holds Pfizer’s shares valued at 478M.


                        Pfizer Stock Analysis

                        Smart ScoreNeutral
                        The Pfizer stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                        Learn more about TipRanks Smart Score

                        Company Description


                        Pfizer Inc. develops, manufactures and sells healthcare products, including innovative medicines and vaccines. Its key focus areas include oncology, inflammation & immunology, rare disease, vaccines and internal medicine. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

                        Similar Stocks
                        Price & Change
                        Johnson & Johnson
                        Eli Lilly & Co
                        Merck & Company
                        Bristol Myers

                        Popular Stocks

                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis